Kristin Hicks

Trump Administration Issues Executive Order To Lower Prescription Drug Costs

September 2024 Medicaid Rebate Final Rule: Key Issues For Manufacturers

Navigating The Pending BIOSECURE Act: Implications For U.S.-China Biopharmaceutical Collaboration And National Security

Arnold & Porter Life Sciences: Pharmaceutical Pricing & Contracting (Video)

Biden Administration Issues Rules Requiring Insurer Transparency On Drug Spending, Rebates And Fees: What Manufacturers Need To Know

Pharmacy Point-Of-Sale Price Concession And PBM Service Fee Safe Harbor Final Rule May Reshape Medicare Part D: What Pharmaceutical Manufacturers Need To Know Now

Coronavirus Legislative Update: Senate Republicans Introduce The HEALS Act COVID-19 Response Legislative Package And Begin Negotiations To Bring A Final Bill To The President's Desk In The Coming Weeks

Executive Order On Regulatory Relief Issued To Support Economic Recovery

The Trump Administration Drug Importation Action Plan

HHS OIG's Proposed Rule: Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals